• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAscelia Pharma AB
    Picture of Ascelia Pharma AB logo

    ACE — Ascelia Pharma AB Share News

    SEK0.560.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      SEK71.37m
    • Enterprise Value
      SEK33.84m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACE Dividends
    • Brief: Ascelia Pharma Q1 Operating Loss Widens To SEK 13.9 Mln

      08/11/2019 07:07
    • Brief: Ascelia Pharma Q4 Operating Loss Widens To SEK 14.5 Million

      22/08/2019 07:14
    • Brief: Ascelia Pharma Files Patent Application For Next Generation Mangoral Product

      10/06/2019 06:59
    • Brief: Ascelia AB Q3 Operating Loss Of SEK 11.7 Mln

      15/05/2019 07:09
    • Brief: Ascelia Pharma Received Supportive Feedback From EMA On Phase 3 Program For Mangoral

      07/05/2019 16:52
    • Brief: Ascelia Pharma says during April, registered number of shares and votes in co has increased

      30/04/2019 13:20
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.